| Autor: |
Kulkarni, Spoorthy, Rieder, Michael, Likic, Robert |
| Předmět: |
|
| Zdroj: |
British Journal of Clinical Pharmacology; Feb2023, Vol. 89 Issue 2, p428-430, 3p |
| Abstrakt: |
2021; 87 (11): 4334 - 4340. doi: 10.1111/bcp.14851 2 Wysowski DK, Swartz L. Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions. Access to de-identified real-world electronic health record databases along with these pharmacovigilance databases and newer statistical methodology in addition has enabled researchers to assess false-positive rates of ADRs attributable to specific drugs or drug classes. The goal of pharmacovigilance is to ensure that therapies are safe to use. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Plný text